Hepatitis E virus antibodies in hemodialysis patients: An epidemiological survey in central Greece

International Journal of Artificial Organs

Volumn 27, Issue 10, 2004, Pages 842-847

  Stefanidis, Ioannis ^a,c   Zervou, E K ^b   Rizos, C ^a   Syrganis, C ^a   Patsidis, E ^a   Kyriakopoulos, G ^a   Sdrakas, L ^a   Tsianas, N ^a   Rigopoulou, E I ^d   Liakopoulos, V ^a   Dalekos, G N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^d NONE

Author keywords

Greece; Hemodialysis patients; Hepatitis E virus; IgG anti HEV; Seroepidemiologic studies

Indexed keywords

BLOOD; DIALYSIS; DISEASES; HEMODIALYZERS; PATIENT TREATMENT; VIRUSES;

AMINOTRANSFERASE; CAUSATIVE AGENTS; GREECE; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS B VIRUS; HEPATITIS E VIRUS; IGG ANTIBODY TO HEV; SEROEPIDEMIOLOGIC STUDY; VIRUS INFECTION;

ANTIBODIES;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS E ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; AMINOTRANSFERASE; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HEMODIALYSIS; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS NON A NON B; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEROEPIDEMIOLOGY; VIRUS TRANSMISSION; BLOOD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COHORT STUDIES; FEMALE; GREECE; HEMODIALYSIS UNITS, HOSPITAL; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; SEROEPIDEMIOLOGIC STUDIES; TRANSAMINASES;

EID: 16644390409     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880402701005     Document Type: Article

References (27)

1. Krawczynski K, Bradley DW. Enterically transmitted non-A, non-B hepatitis: Identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis 1989; 159: 1042-9.
2. Schlauder GG, Mushahwar IK. Genetic heterogeneity of hepatitis E virus. J Med Virol 2001; 65: 282-92.
3. Aggarwal R, Krawczynski K. Hepatitis E: An overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 2000; 15: 9-20.
4. Gupta DN, Smetana HF. The histopathology of viral hepatitis as seen in the Delhi epidemics (1955-56). Indian J Med Res 1957; 45: 101-13.
5. Khuroo MS, Saleem M, Teli MR, Sofi MA. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet 1980; 2: 97-8.
6. Psichogiou MA, Tassopoulos NC, Papatheodoridis GW, Tzala E, Klarmann R, Witteler H et al. Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis. J Hepatol 1995; 23: 668-73.
7. Gessoni G, Manoni F. Hepatitis E virus infection in north-east Italy: Serological study in the open population and groups at risk . J Viral Hepat 1996; 3: 197-202.
8. Dalekos GN, Zervou E, Elisaf M, Germanos N, Galanakis E, Bourantas K, et al. Antibodies to hepatitis E virus among several populations in Greece: Increased prevalence in an hemodialysis unit. Transfusion 1998; 38: 589-95.
9. Halfon P, Ouzan D, Chanas M, Khiri H, Feryn JM, Mangin L, et al. High prevalence of hepatitis E virus antibody in haemodialysis patients (Letter). Lancet 1994; 344: 746.
10. Knodler B, Hiller J, Loliger CC, Kuhnl L. Hepatitis E Antikörper bei Blutspendern, Hämodialysepatienten und im Normalkollektiv. Beitr Infusionsther Transfusionsmed 1994; 32: 124-7: 124-7.
11. Arinsoy T, Yilmaz M, Derici U, Sindel S, Tekin I, Hasanoglu E. Prevalence of hepatitis E virus antibody in hemodialysis patients. Nephron 1998; 80: 85.
12. Courtney MG, O'Mahoney M, Albloushi S, Sachithanandan S, Walshe J, Carmody M, et al. Hepatitis E virus antibody prevalence. Lancet 1994; 344: 1166.
13. Fabrizi F, Lunghi G, Bacchini G, Corti M, Pagano A, Locatelli F. Hepatitis E virus infection in haemodialysis patients: A seroepidemiological survey. Nephrol Dial Transplant 1997; 12: 133-6.
14. Mateos ML, Teruel JL, Sierra MP, Gazapo E. High prevalence of hepatitis E virus antibodies in Spanish hemodialysis patients. Nephron 1997; 76: 231-2.
15. Psichogiou M, Vaindirli E, Tzala E, Voudiclari S, Boletis J, Vosnidis G, et al. Hepatitis E virus (HEV) infection in haemodialysis patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1996; 11: 1093-5.
16. Sylvan SP, Jacobson SH, Christenson B. Prevalence of antibodies to hepatitis E virus among hemodialysis patients in Sweden. J Med Virol 1998; 54: 38-43.
17. Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG, Alter MJ, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol 1992; 36: 246-50.
18. Goldsmith R, Yarbough PO, Reyes GR, Fry KE, Gabor KA, Kamel M et al. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 1992; 339: 328-31.
19. Lin CC, Wu JC, Chang TT, Chang WY, Yu ML, Tam AW, et al. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Virol 2000; 38: 3915-8.
20. Dalekos GN, Zervou E, Karabini F, Elisaf M, Bourantas K, Siamopoulos KC. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece. Transfusion 1995; 35: 503-6.
21. Zervou EK, Boumba DS, Liaskos C, Georgiadou S, Tsianos EV, Dalekos GN. Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: Results of a 3-year prospective donor study (1995-1997). Eur J Intern Med 2003; 14: 39-44.
22. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000; 54: 151-6.
23. Fabrizi F, Lunghi G, Andrulli S, Pagliari B, Mangano S, Faranna P, et al. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transplant 1997; 12: 1394-8.
24. Chauhan A, Jameel S, Dilawari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer. Lancet 1993; 341: 149-50.
25. Nanda SK, Ansari IH, Acharya SK, Jameel S, Panda SK. Protracted viremia during acute sporadic hepatitis E virus infection. Gastroenterology 1995; 108: 225-30.
26. Schlauder GG, Dawson GJ, Mushahwar IK, Ritter A, Sutherland R, Moaness A et al. Viraemia in Egyptian children with hepatitis E virus infection. Lancet 1993; 341: 378.
27. Ayoola EA, Want MA, Gadour MO, Al Hazmi MH, Hamza MK. Hepatitis E virus infection in haemodialysis patients: A case-control study in Saudi Arabia. J Med Virol 2002; 66: 329-34.